Journal Article Summary
The article investigates the impact of endogenous estradiol on vascular endothelial function in premenopausal women with type 1 diabetes. This topic is significant because cardiovascular disease (CVD) is a leading cause of death, and women with type 1 diabetes face a higher risk of developing CVD compared to their male counterparts. While estrogen is generally considered protective against heart disease in healthy women, its effects may differ in those with diabetes, potentially leading to vascular dysfunction.
The study involved 32 women with type 1 diabetes and 25 healthy controls, examining their endothelial function during different phases of the menstrual cycle. Researchers measured flow-mediated dilation (FMD), which indicates how well blood vessels can expand, alongside blood samples to assess estradiol levels and oxidative stress markers. Results showed that while estradiol levels increased during the late follicular phase in both groups, only women with type 1 diabetes experienced a rise in oxidative stress. Notably, FMD decreased in women with diabetes during this phase, contrasting with an increase observed in healthy controls. Additionally, women with type 1 diabetes using hormonal birth control (HBC) showed better endothelial function compared to those not using it.
Limitations of the study include a small sample size and the inability to establish cause-and-effect relationships. The findings suggest that endogenous estradiol may contribute to vascular dysfunction in women with type 1 diabetes, which could increase their risk of CVD. Patients are encouraged to discuss these findings with healthcare professionals, particularly regarding the potential benefits of HBC and the management of cardiovascular health in the context of diabetes.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Simon Abigayle B., Derella Cassandra C., Blackburn Marsha, Thomas Jeffrey, Layman Lawrence C., Nicholson Matthew S., Waller Jennifer, Elmarakby Ahmed, et al.. Endogenous estradiol contributes to vascular endothelial dysfunction in premenopausal women with type 1 diabetes. Cardiovascular Diabetology 2023. DOI: 10.1186/s12933-023-01966-6. PMID: 37679748. PMCID: PMC10486136.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
